2B reitbartW,Chand ler S,Eagel B,et al.An alternative algorithm for do-sing transdermal fentanyl for cancer-related pain. Oncology (W illistonPark) . 2000
3NCCN clinical practice guidelines in oncology-colon cancer guideline(OL)http://www.nccn.org/professionals/physiciangls/PDF/colon . 2011
6Davis M P, Walsh D. Epidemiology of cancer pain and factors in- fluencing poor pain control[J]. Am J Hosp Palliat Care,2004, 21(2): 137-142.
7NCCNJqCCN Guidelines,Adult Cancer Pain,Version 22012 [EB/OL]. (2012-09-26)[2013-10-20]http://wenku.baidu.com/view/3d3a- 9d61 led9ad51 f01df211.html.
8Biswa M B. Current trends in the management of oral mucositis related to cancer treatment. Malaysian loumal of Medical Science, 2008,15(3):4-13.
9Chi K FL Chen C H, Chart W K, et al. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil and leucovorin chemotherapy[J]. J Clin Oncol 1995, 13(10): 2620-2628.
10Wardley A M, Scarffe J H. Role of granulocyte-macrophage colony-stimulating factor in chemotherapy-induced oral mucositis[J]. J Clin Oncol, 1996, 14(5):1741-1743.
